Search
-
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
(PLoS ONE. vol. 18, n° 1, pp. e0266985, 2023-04-05)Article de revueOpen access -
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
(PLoS Neglected Tropical Diseases. vol. 18, n° 4, pp. e0011500, 2024-04-11)Article de revueOpen access -
Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report
(Infectious Disease Modelling. vol. 9, n° 2, pp. 501-518, 2024-06-01)Article de revueOpen access -
Interdisciplinary and differentiated learning of Statistics in an online MPH
Communication dans un congrèsOpen access -
CRP under 130 mg/L rules out the diagnosis of Legionella pneumophila serogroup 1 (URINELLA Study)
(European Journal of Clinical Microbiology & Infectious Diseases, 2024-03-26)Article de revueOpen access -
Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study)
(Scientific Reports. vol. 13, n° 1, pp. 16535, 2023-10-02)Article de revueOpen access -
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
(International Journal of Epidemiology. vol. 53, n° 1, 2024-02-01)Article de revueOpen access -
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol
(BMC Infectious Diseases. vol. 24, n° 1, pp. 329, 2024-03-19)Article de revueOpen access -
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates
(PLoS Computational Biology. vol. 19, n° 8, pp. e1010721, 2023-08-09)Article de revueOpen access -
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
(Lancet Global Health. vol. 11, n° 11, pp. e1743-e1752, 2023-11)Article de revueOpen access